Objective To ascertain the prevalence of myocardial infarction (MI) in ankylosing spondylitis
(AS) relative to that in the general population. Methods A questionnaire was sent to 593 …

Objective. To investigate whether use of adalimumab decreases the frequency of attacks of
anterior uveitis (AU) in patients with ankylosing spondylitis (AS). Methods. Consecutive …

Ann Rheum Dis May 2011 Vol 70 No 5 876 patients with PsA and the general population.
Owing to the response rate of 65%, the CV prevalence in PsA might be overestimated as …

The aim of this cohort study was to evaluate the long‐term effects of TNF inhibitors (TNFis)
on BMD and the incidence of vertebral fractures (VFxs) in patients with ankylosing …

Background Effective anti-inflammatory treatment with tumour necrosis factor α (TNFα)
inhibitors may have favourable effects on the lipid profile. Available evidence is derived from …

Objective To assess gender differences in body composition (BC) in a cohort of AS patients
naïve to TNF-α blockers. Methods Patients included fulfilled the Modified New York criteria …

Objective. Our main objective was to assess the relationship between body composition
(BC) and response to tumor necrosis factor-α (TNF-α) blocker treatment in patients with …

Objective C-reactive protein (CRP) levels are frequently used to determine disease activity
in patients with ankylosing spondylitis (AS), but these levels may not reflect disease activity …

Objective To examine the prevalence of hip involvement between sexes in patients with
ankylosing spondylitis (AS) treated with tumor necrosis factor inhibitors (TNFi) and to …

Background and aims Rheumatoid arthritis (RA) patients are currently treated with biological
agents mostly aimed at cytokine blockade, such as tumor necrosis factor-alpha (TNFα) …